✦ LIBER ✦

Benefit-risk paradigm for clinical trial design of obesity devices: FDA proposal

✍ Scribed by Mark A. Talamini

Book ID: 120910785
Publisher: Springer
Year: 2013
Tongue: English
Weight: 144 KB
Volume: 27
Category: Article
ISSN: 0930-2794
DOI: 10.1007/s00464-012-2726-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Benefit-risk paradigm for clinical trial

Benefit-risk paradigm for clinical trial design of obesity devices: FDA proposal

✍ Herbert Lerner, Joyce Whang, Rebecca Nipper 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 223 KB

Erratum to: Benefit-risk paradigm for cl

Erratum to: Benefit-risk paradigm for clinical trial design of obesity devices: FDA proposal

✍ Herbert Lerner, Joyce Whang, Rebecca Nipper 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 151 KB

FDA perspective on clinical trial design

FDA perspective on clinical trial design for femoropopliteal stent correction of peripheral vascular insufficiency cardiovascular devices

✍ Jennifer Goode; Wolf Sapirstein; Bram Zuckerman 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

The article by Rocha-Singh et al. [1]. on behalf of the VIVA Physicians Incorporate (VPI) in this issue of the Catheterization and Cardiac Interventions addresses the challenge to designing clinical trials for devices intended to correct femoropopliteal arterial insufficiency. As discussed in this a